Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
NCT02538562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1695
Last updated 2017-07-11
Summary
This study is designed to gather epidemiological data in Korea on HER2 incidence in gastric and gastroesophageal junction cancer as assessed by local laboratories in a real-life setting. No investigational products will be provided or evaluated.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-11
- Primary Completion
- 2013-04-19
- Completion
- 2013-04-19
Countries
- South Korea
Study Locations
More Related Trials
-
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT04253106 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
ctDNA Screening in Advanced HER2 Positive Gastric Cancer
NCT04520295 ·Status: UNKNOWN
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer
NCT05541874 ·Status: NOT_YET_RECRUITING
-
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
NCT02067754 ·Status: COMPLETED
-
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551 ·Status: COMPLETED
-
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
NCT04576858 ·Status: UNKNOWN
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model
NCT02141152 ·Status: COMPLETED
-
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
NCT04651920 ·Status: COMPLETED
-
Newer Therapeutic Targets in Head and Neck Cancers
NCT05382585 ·Status: RECRUITING
-
Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
NCT04600466 ·Status: TERMINATED
-
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
NCT02597179 ·Status: UNKNOWN
-
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
NCT00963092 ·Status: UNKNOWN
-
Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer
NCT06023121 ·Status: COMPLETED
-
Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer
NCT05336058 ·Status: COMPLETED
-
Personalized Sequence for Thoracic, Esophageal, and H&N Cancer
NCT02299622 ·Status: UNKNOWN
-
Genetic Characteristics of Metastatic Breast Cancer Patients
NCT04258735 ·Status: UNKNOWN ·Phase: NA
-
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
NCT03030404 ·Status: COMPLETED
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
NCT05400018 ·Status: COMPLETED
-
A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
NCT06925113 ·Status: COMPLETED
-
Identification of Prognostic Gene Mutations in Biliary Tract Cancer Using Whole Genome Sequencing
NCT03718897 ·Status: UNKNOWN
-
Cancer Genome Analysis
NCT01458704 ·Status: UNKNOWN